Taysha Gene Therapies
0 followers
‌
Taysha Gene Therapies is on a mission to eradicate severe and life-threatening monogenic CNS disease. With a singular focus on developing curative medicines, they hope to rapidly translate their treatments from bench to bedside.
Industries
Headquarters
Employees
Links
Org chart
Sean Nolan
Chief Executive Officer
Sean Nolan
Collapse
Sukumar Nagendran
President
Kamran Alam
Chief Financial Officer
Tracy M. Porter
Chief People Officer
Sean Mcauliffe
Chief Business Officer
Fred Porter
Chief Technical Officer
Emily McGinnis
Chief Patient And External Affairs Officer
Andy Lorenc
Vice President, Engineering
Rumana Haque-Ahmed
Chief Regulatory Officer
Tammie Mitchell
VP, Total Rewards
Chelsea Karbocus
Executive Director, Head Of Patient Advocacy
Eshetu Tesfaye
Ex. Director, Biostatistics
Melissa A. Ellis
Senior Executive Assistant to the Chairman & CEO
Hayleigh Collins
Director, Head Of Corporate Communications And Investor Relations
Patrick Nolan
Director, Business Development & R&d Chief Of Staff
Andrew Wallace
Principal Scientist
Donnielle Minor
Program Manager
Selene Barbosa Cardenas
Sr. Research Associate
Ryan Chaparian, Ph.D.
Scientist Ii, Bioanalytics
Ian Jones
Senior Research Associate
Tanita Mason-Bright
Director Clinical Operations
Shomari Hogan
Director Medical Affairs
Cheryl Demos Fludas
Vice President Clinical Operations
